Korro Bio, Inc.
KRRO•NASDAQ•Healthcare•Biotechnology

About Korro Bio

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Company Information

SectorHealthcare
IndustryBiotechnology
CEORam Aiyar
Founded2014
IPO DateOctober 3, 2019
Employees104
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.korrobio.com
Phone617 468 1999
Address
One Kendall Square, Building 600-700 Cambridge, Massachusetts 02139 United States

Corporate Identifiers

CIK0001703647
CUSIP500946108
ISINUS5009461089
EIN47-2324450
SIC2834

Leadership Team & Key Executives

Dr. Ram Aiyar MBA, Ph.D.
Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer and Director
Jeffrey M. Cerio J.D., Pharm.D.
Senior Vice President, General Counsel and Corporate Secretary
Dr. Olukemi A. Olugemo M.D.
Advisor
Dr. Andrew Fraley Ph.D.
Co-Founder and Advisor
Dr. Joshua Rosenthal Ph.D.
Co-Founder and Advisor
Todd Chappell M.B.A.
Chief Operating Officer
Oliver Dolan
Senior Vice President of Finance and Principal Accounting Officer
Dr. Loic Vincent Ph.D.
Chief Scientific Officer
Stephanie Engels
Chief People Officer
Dr. Gaozhong Zhu Ph.D.
SVice President of Chemistry, Manufacturing and Controls and Technical Operations